Purpose of Tripp's call?Curious to find out the purpose of Tripp's scheduled conference call this coming Thursday. Is this a promotional exercise to get the word out there about IDL being up and running in order to help generate more testing? Is this a platform to announce a new collaboration? Will he simply highlight the speaking points from last quarter's release? I would bet he will speak to Breastsentry and it's availability. He says that this conference call is in response to investor and media inquiries regarding operation and partnership activities. Well, it's obvious that investors want to know the rate of testing ramp up? This question AND cash flow/burn rate must be the most obvious on the minds of investors... Tripp must know this. So will he answer these questions? If it's just a publicity stunt to buy him some more time, that certainly will not be well received. Time to be clear and to the point James! We would like current results and realistic projections. Otherwise, no point in holding this call.